Arvind Sehgal

Prof. Arvind Sehgal

1. Neonatal Cardiovascular Research, Monash Children's Hospital, Clayton, Melbourne ZIP 3168, Australia
+1
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Pediatric Research
Verified
Journal Article
Open access
PDF file
O(on behalf of the European Special Interest Group ‘Neonatologist Performed Echocardiography’ (NPE)
on behalf of the European Special Interest Group ‘Neonatologist Performed Echocardiography’ (NPE)
WBWillem P. de Boode
Willem P. de Boode
Yogen SinghYogen Singh
Yogen Singh
ZMZoltan Molnar
Zoltan Molnar
USUlf Schubert
Ulf Schubert
AEAfif El-Khuffash
Afif El-Khuffash
Pulmonary hypertension contributes to morbidity and mortality in both the term newborn infant, referred to as persistent pulmonary hypertension of the newborn (PPHN), and the premature infant, in the setting of abnormal pulmonary vasculature development and arrested growth. In the term infant, PPHN is characterized by the failure of the physiological postnatal decrease in pulmonary vascular resistance that results in impaired oxygenation, right ventricular failure, and pulmonary-to-systemic shunting. The pulmonary vasculature is either maladapted, maldeveloped, or underdeveloped. In the premature infant, the mechanisms are similar in that the early onset pulmonary hypertension (PH) is due to pulmonary vascular immaturity and its underdevelopment, while late onset PH is due to the maladaptation of the pulmonary circulation that is seen with severe bronchopulmonary dysplasia. This may lead to cor-pulmonale if left undiagnosed and untreated. Neonatologist performed echocardiography (NPE) should be considered in any preterm or term neonate that presents with risk factors suggesting PPHN. In this review, we discuss the risk factors for PPHN in term and preterm infants, the etiologies, and the pathophysiological mechanisms as they relate to growth and development of the pulmonary vasculature. We explore the applications of NPE techniques that aid in the correct diagnostic and pathophysiological assessment of the most common neonatal etiologies of PPHN and provide guidelines for using these techniques to optimize the management of the neonate with PPHN.

1 November 2013 in The Journal of Pediatrics
Verified
Journal Article
Closed access
Arvind SehgalArvind Sehgal
Arvind Sehgal
TDTejas Doctor
Tejas Doctor
SMSamuel Menahem
Samuel Menahem

13 June 2018 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
Arvind SehgalArvind Sehgal
Arvind Sehgal
SGStella M. Gwini
Stella M. Gwini
SMSamuel Menahem
Samuel Menahem
BABeth J. Allison
Beth J. Allison
Suzanne L MillerSuzanne L Miller
Suzanne L Miller
GPGraeme R. Polglase
Graeme R. Polglase
Key points: Approximately 5–10% pregnancies are affected by fetal growth restriction. Preterm infants affected by fetal growth restriction have a higher incidence of bronchopulmonary dysplasia. The present study is the first to measure pulmonary artery thickness and stiffness. The findings show that impaired vasculogenesis may be a contributory factor in the higher incidence of bronchopulmonary dysplasia in preterm growth restricted infants. The study addresses the mechanistic link between fetal programming and vascular architecture and mechanics. Bronchopulmonary dysplasia is the most common respiratory sequelae of prematurity and histopathologically features fewer, dysmorphic pulmonary arteries. The present study aimed to characterize pulmonary artery mechanics and cardiac function in preterm infants with fetal growth restriction (FGR) compared to those appropriate for gestational age (AGA) in the early neonatal period. This prospective study reviewed 40 preterm infants between 28 to 32 weeks gestational age (GA). Twenty infants had a birthweight <10th centile and were compared with 20 preterm AGA infants. A single high resolution echocardiogram was performed to measure right pulmonary arterial and right ventricular (RV) indices. The GA and birthweight of FGR and AGA infants were 29.8 ± 1.3 vs. 30 ± 0.9 weeks (P = 0.78) and 923.4 g ± 168 vs. 1403 g ± 237 (P < 0.001), respectively. Assessments were made at 10.5 ± 1.3 days after birth. The FGR infants had significantly thicker right pulmonary artery inferior wall (843.5 ± 68 vs. 761 ± 40 μm, P < 0.001) with reduced pulsatility (51.6 ± 7.6 μm vs. 59.7 ± 7.5 μm, P = 0.001). The RV contractility [fractional area change (28.7 ± 3.8% vs 32.5 ± 3.1%, P = 0.001), tricuspid annular peak systolic excursion (TAPSE) (5.2 ± 0.3% vs. 5.9 ± 0.7%, P = 0.0002) and myocardial performance index (0.35 ± 0.03 vs. 0.28 ± 0.02, P < 0.001)] was significantly impaired in FGR infants. Significant correlation between RV longitudinal contractility (TAPSE) and time to peak velocity/RV ejection time (measure of RV afterload) was noted (r2 = 0.5, P < 0.001). Altered pulmonary vascular mechanics and cardiac performance reflect maladaptive changes in response to utero‐placental insufficiency. Whether managing pulmonary vascular disease will alter clinical outcomes remains to be studied prospectively.

1 July 2018 in Pediatric Research
Verified
Journal Article
Open access
PDF file
PLPhilip Thaler Levy
Philip Thaler Levy
CTCécile Tissot
Cécile Tissot
BEBeate Horsberg Eriksen
Beate Horsberg Eriksen
ENEirik Nestaas
Eirik Nestaas
SRSheryle Rogerosn
Sheryle Rogerosn
LWLizelle Van Wyk
Lizelle Van Wyk
Neonatal heart failure (HF) is a progressive disease caused by cardiovascular and non-cardiovascular abnormalities. The most common cause of neonatal HF is structural congenital heart disease, while neonatal cardiomyopathy represents the most common cause of HF in infants with a structurally normal heart. Neonatal cardiomyopathy is a group of diseases manifesting with various morphological and functional phenotypes that affect the heart muscle and alter cardiac performance at, or soon after birth. The clinical presentation of neonates with cardiomyopathy is varied, as are the possible causes of the condition and the severity of disease presentation. Echocardiography is the selected method of choice for diagnostic evaluation, follow-up and analysis of treatment results for cardiomyopathies in neonates. Advances in neonatal echocardiography now permit a more comprehensive assessment of cardiac performance that could not be previously achieved with conventional imaging. In this review, we discuss the current and emerging echocardiographic techniques that aid in the correct diagnostic and pathophysiological assessment of some of the most common etiologies of HF that occur in neonates with a structurally normal heart and acquired cardiomyopathy and we provide recommendations for using these techniques to optimize the management of neonate with HF.

1 September 2017 in The Journal of Pediatrics
Verified
Journal Article
Closed access
Arvind SehgalArvind Sehgal
Arvind Sehgal
Beth J. AllisonBeth J. Allison
Beth J. Allison
SGStella M. Gwini
Stella M. Gwini
Suzanne L MillerSuzanne L Miller
Suzanne L Miller
GPGraeme R Polglase
Graeme R Polglase

22 March 2015 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
KTKenneth Tan
Kenneth Tan
MKMohan B. Krishnamurthy
Mohan B. Krishnamurthy
JOJosie L. O’hEney
Josie L. O’hEney
EPEldho Paul
Eldho Paul
Arvind SehgalArvind Sehgal
Arvind Sehgal